Clinical Trials on Type 2 Diabetes, Chronic Kidney Disease in Belgium

Total 628 results

Poitiers University Hospital
Hospices Civils de Lyon; Centre Hospitalier Universitaire Dijon; University Hospital... and other collaborators

Recruiting

Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes (ACTIDIANE)

Diabetic Kidney Disease | Type2 Diabetes

France, Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery (MYDIASECRET)

Diabete Type 2

Belgium
Hasselt University
Jessa Hospital

Completed

Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy

Type2 Diabetes | Diabetic Cardiomyopathies

Belgium
Lexicon Pharmaceuticals
Sanofi

Terminated

Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk (SCORED)

Heart Failure | Chronic Kidney Diseases | Type 2 Diabetes Mellitus

Estonia, Belgium, Sweden, Italy, China, United States, Canada, Bulgaria, Chile, Denmark, Hungary, Latvia, Mexico, Russian Federation, Serbia, Spain, Portugal, Romania, Turkey, Poland, Lithuania, Argentina, Australia, Brazil, Czechia, France, Georg... and more
University of Liege
EGID, Lille

Unknown

Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications (PreciDiag)

Diabete Type 2

Belgium
Bayer

Completed

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD)

Chronic Kidney Disease

Belgium, Finland, France, China, Hong Kong, Switzerland, United States, Turkey, Greece, New Zealand, Poland, South Africa, Spain, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, ... and more
University Ghent

Completed

Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Adults With Type 2 Diabetes

Chronic Disease

Belgium
Bayer

Completed

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease (FIGARO-DKD)

Diabetic Kidney Disease

Belgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
Bayer

Recruiting

A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes (CONFIDENCE)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States, Belgium, Spain, Taiwan, Korea, Republic of, Japan, Italy, Denmark, Israel, Canada, France, India, Netherlands, Germany
University Ghent
BOF

Completed

Controlled Outcome Evaluations of a Daily Physical Activity Intervention for Individuals With Type 2 Diabetes

Type 2 Diabetes

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes

Type 2 Diabetes Mellitus

Belgium
University Ghent

Completed

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

Diabetes Mellitus

Belgium
Ziekenhuis Oost-Limburg
Ziekenhuis Oost-Limburg

Recruiting

Characteristics of NAFLD Among Type 2 Diabetes Patients

Type2 Diabetes | Non-Alcoholic Fatty Liver Disease

Belgium
Erasme University Hospital

Terminated

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Type 2 Diabetes | Pancreas | Incretinomimetics

Belgium
India Diabetes Research Foundation & Dr. A. Ramachandran...

Completed

A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients

Type2 Diabetes

India
Bayer

Recruiting

A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting

Type 2 Diabetes Mellitus | Chronic Kidney Disease

United States, Germany, Argentina, Belgium, Brazil, Canada, Chile, Colombia, France, Italy, Korea, Republic of, Luxembourg, Mexico, Netherlands, Russian Federation, Saudi Arabia, Singapore, Slovenia, Spain, Switzerland, Taiwan, Th... and more
Universitaire Ziekenhuizen KU Leuven

Completed

Acute Effect of Rebaudioside A on Glucose Excursion During an Oral Glucose Tolerance Test in Type 2 Diabetes Mellitus (AREBAG)

Type 2 Diabetes Mellitus

Belgium
Bayer

Completed

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants (FIGARO-BM)

Type 2 Diabetes Mellitus | Chronic Kidney Disease

Spain, Belgium, United States, Russian Federation, Hong Kong, Singapore, Taiwan, Korea, Republic of, Canada, Austria, Italy, Japan, Denmark, Australia, Bulgaria, Czechia, Finland, Israel, Netherlands, Sweden, Portugal
Canterbury Christ Church University
Kinetic Analysis; Medway Community Healthcare; Blackthorn Trust; Arteveldehoges... and other collaborators

Completed

Evaluation of Diabetes and WELLbeing Programme (DWELL)

Type 2 Diabetes | Type 2 Diabetes Treated With Insulin

Belgium, France, Netherlands, United Kingdom
Indigo Diabetes NV

Completed

The SHINE Study: Safety of Implant and Preliminary Performance of the SHINE SYSTEM in Diabetic Subjects

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Hypoglycemia | Diabetes Mellitus, Type 1 | Ketoacidosis, Diabetic | Hyperglycaemia (Diabetic)

Belgium, Slovenia, France
Hasselt University
KU Leuven; Jessa Hospital; University Ghent

Recruiting

Prevention of Heart Failure in Type 2 Diabetes by Exercise Intervention (PROTECTION)

Type 2 Diabetes

Belgium
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)

Type 2 Diabetes Mellitus

India
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

Psoriasis | Type 2 Diabetes

Belgium
Sahlgrenska University Hospital, Sweden
Karolinska Institutet; Imperial College London; University Hospital, Ghent; Universitair... and other collaborators

Completed

Early Glycaemic Control in Type 2 Diabetes Patients After Bariatric Surgery; ECODABS

Diabetes Mellitus Type 2 in Obese

Spain, Sweden, Belgium, United Kingdom
University Hospital, Gasthuisberg

Completed

The Effect of a Gastric Bypass on Type 2 Diabetes in the Morbidly Obese Patient

Type 2 Diabetes | Morbid Obesity

Belgium
Pfizer

Completed

Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

Diabetes Mellitus, Type II

Belgium
ChemoCentryx

Completed

A Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects With Diabetic Nephropathy

Type 2 Diabetes Mellitus | Diabetic Nephropathy

Poland, United Kingdom, Germany, Belgium, Hungary, Czechia
Sanofi

Completed

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

Type 2 Diabetes Mellitus

France, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
European Society of Intensive Care Medicine

Completed

PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy (PEACE)

Acute Kidney Injury | Renal Replacement Therapy | Chronic End Stage Kidney Disease

Belgium
Ziekenhuis Oost-Limburg

Active, not recruiting

Prevalence of NAFLD in T2DM Patients (PAD2ZOL)

Type 2 Diabetes | NAFLD | Fatty Liver, Nonalcoholic | T2D

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Multidisciplinary Care for Patients With Chronic Kidney Disease to Increase Their Self-management.

Chronic Kidney Diseases

Belgium
Novo Nordisk A/S

Completed

Switch From Metformin Monotherapy to a Bitherapy With Metformin and Repaglinide (REPAMET 2)

Diabetes Mellitus, Type 2 | Diabetes

Belgium
Novo Nordisk A/S

Completed

Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes (ROOTS)

Diabetes Mellitus, Type 2 | Diabetes

Belgium
Universitaire Ziekenhuizen KU Leuven
General Hospital Groeninge

Completed

Nephrocare mHealth Project: Telemonitoring of Blood Pressure (Nephrocare)

Chronic Kidney Diseases | Blood Pressure

Belgium
Novo Nordisk A/S

Completed

Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes (REPAMET)

Diabetes Mellitus, Type 2 | Diabetes

Luxembourg, Belgium
Novo Nordisk A/S

Completed

Observational Study Evaluating the Safety of NovoMix® in Type 2 Diabetes Patients Previously Treated With a Human Premix Insulin (Mix2Mix)

Diabetes Mellitus, Type 2 | Diabetes

Belgium, Luxembourg
Centre d'Etudes et de Recherche pour l'Intensification...

Completed

Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk (DESCENDANCE)

Type 2 Diabetes

France, Belgium
Eli Lilly and Company

Completed

Safety, Tolerability, and Effect of LY2405319 After Multiple Injections in Subjects With Type 2 Diabetes

Type 2 Diabetes

India, Mexico, New Zealand, South Africa
Hasselt University
Hochschule Geisenheim University

Completed

Orange Juice and Glycaemic Control in Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2

Belgium
Pfizer

Completed

A Study Of PF-03882845 Absorption In Healthy Volunteers Given Orally As Tablet Versus Suspension Formulations And Effect Of Food On Its Absorption

Diabetes Mellitus, Type 2

Belgium
KU Leuven

Completed

Impact of an Evidence-based Electronic Decision Support System on Diabetes Care

Diabetes Mellitus, Type 2

Belgium
University Hospital, Ghent
University Ghent

Recruiting

24-hour Movement Behaviors Among Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Belgium
Pfizer

Terminated

A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-Weeks

Diabetes Mellitus, Type 2

Belgium
Novo Nordisk A/S

Active, not recruiting

A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease (FLOW)

Diabetes Mellitus, Type 2

Spain, United Kingdom, United States, Australia, India, Canada, Turkey, Netherlands, Italy, Poland, China, Germany, Malaysia, Israel, Hungary, Ukraine, Japan, South Africa, Russian Federation, Brazil, France, Bulgaria, Belgium, Thailand, Gree... and more
AZ Sint-Jan AV
Pfizer

Completed

13 Valent Pneumococcal Conjugate Vaccine in Chronic Dialysis Patients

Chronic Kidney Failure

Belgium
Universitaire Ziekenhuizen KU Leuven

Suspended

Albumin Dialysis in End-Stage Renal Disease: Detoxification Capacity and Impact on Vascular Endothelial Function

Chronic Kidney Disease

Belgium
University Hospital, Ghent
Agentschap voor Innovatie door Wetenschap en Technologie; University Ghent

Completed

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Kinetic Analysis (UToPaed_2)

Chronic Kidney Disease

Belgium
University Hospital, Ghent
Agentschap voor Innovatie door Wetenschap en Technologie; University Ghent

Completed

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Interventional Study (UToPaed_3)

Chronic Kidney Disease

Belgium
EXcorLab GmbH
Nipro Europe N.V.

Completed

Test of the Nipro ELISIO H Dialyzer in Different Dialysis Treatment Procedures

Chronic Kidney Disease

Belgium
University Hospital, Ghent
Agentschap voor Innovatie door Wetenschap en Technologie; University Ghent

Completed

Uraemic Toxins in Chronic Kidney Disease Paediatric Patients: Observational Study (UToPaed_1)

Chronic Kidney Disease

Belgium

Clinical Trials on Type 2 Diabetes, Chronic Kidney Disease in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations